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of hope for a brilliant future‘‘Do not fear to be eccentric in opinion, for every opinion now
accepted was once eccentric’’. – Bertrand Russell (1872–1970)
The evolution of lacrimal disorders and its management
amply exemplifies the above stated quote of the 20th century
British philosopher Bertrand Russell. Lacrimal surgeries have
been a subject of discussion in antiquity with the earliest doc-
umented reference being a lacrimal sac incision in the ‘Code
of Hammurabi’ in 2250 BC.1 The past which appears glorious
today had once traveled through many tough terrains in an-
cient times nurtured by the Egyptians (Ebers Papyrus –
1500 BC), the Greeks (Hippocrates and Celcus – 25 BC)
and the Romans (Galen – 200 AD).1,2 The Arabians chipped
in between with their contributions from Ibn Sina and Al Razi
in the medieval times. The Modern Dacryology was given
impetus with the hallmark anatomical works of Giovanni Mor-
gagni (1682–1771) and Johann Zinn (1727–1759) and equally
by the influential lacrimal treatises by Percival Pott (1714–
1788) and Johann Schmidt (1759–1809).3
‘Men love to wonder and that is the seed of science’, said
the famous 19th century American poet, Ralph Waldo Emer-
son. Lacrimal surgeries have undergone a sea change in the
last two centuries. The original Woolhouse technique (1724)
of dacryocystectomy underwent numerous changes in tech-
niques and approaches to the present age but with progres-
sively lesser indications. The external dacyrocystorhinostomy
(DCR) had a steeper evolution for obvious reasons from the
times when Addeo Toti (1904) first described it to the current
day practice with various incisions and lacrimal sac
implants.4,5 With the introduction of rigid endoscopy and
better view, endonasal dacyrocystorhinostomy showed a
steep resurgence into the practice,6 more than a century
after its original description7 failed to gain wider acceptance.
Endocanalicular laser DCR, however till the present date has
failed to gain widespread acceptance despite numerous
modifications since its introduction to Dacryology by Levin
and Stormogipson in 1992.8,9 Likewise was the journey of
trans-conjunctival DCR (CDCR), which evolved into endo-
scopic and lesser invasive approaches along with numerous
Jones tube modifications.10,11 Balloon dacryoplasty has
evolved mostly in terms of indications rather than instrumen-
tation or techniques.12,13
The present era of lacrimal practice is both exciting and at
the same time challenging. The state of art equipments
including high definition endoscopic systems, diagnostic
and therapeutic dacryoendoscopy and higher resolution yetPeer review under responsibility
of Saudi Ophthalmological Society,
King Saud Universitysafer imaging are increasingly contributing toward our under-
standing of the disorders as well as developing minimally
invasive surgical options. Many debates today are centered
on the approaches to a DCR, ostium size, mitomycin C and
intubation. The most recent meta-analysis has been able to
shed much needed light into these areas with clinical implica-
tions.14,15 The PEDIG studies have helped greatly in the man-
agement of congenital nasolacrimal duct obstructions in
terms of clinical decision making and outcomes.16,17 There
is an increasing focus on the Natural Orifice Transcanalicular
Endoscopic Surgery (NOTES) for both canalicular and naso-
lacrimal duct recanalizations under dacryoendoscopic guid-
ance in an effort to avoid a DCR.18 Although NOTES is
quite promising, skepticism is very well justified at this stage.
The present era is also taking many attempts to standardize
the nomenclatures,19 drug dosage,20 introduction of newer
terminologies21 and paradigm shifts in the understanding of
lacrimal anatomy.22,23 The armamentarium of a lacrimal sur-
geon today is more well equipped than any other time and
this very fact brings in more responsibility on us than any
other time, to take this forward in every possible way in the
future!
The audacity of hope and optimism points toward a
brighter future for the patients of tomorrow with lacrimal
disorders. However, despite some of the advances high-
lighted, we still have a long way to go in our understanding
and treatment of lacrimal disorders. This would require work
on two different fronts with concurrent amalgamation. The
first front should be science related and let the second be re-
lated to the surgeon. On the science frontier, the need of
hour is to demystify the etiopathogenesis of lacrimal disor-
ders primarily that of primary acquired nasolacrimal duct
obstruction or PANDO. It would be inappropriate to con-
tinue managing lacrimal disorders mechanically without
simultaneous efforts to unravel the elusive etiopathogenesis.
The key to this, I believe lies with the basic sciences. Embry-
onic studies to look for regulatory proteins influencing lacri-
mal primordium and sub adjacent mesenchyme of surface
ectoderm during Carnegie stages of development may hold
promising clues to understanding of congenital lacrimal dis-
orders. Cytochemical analysis was performed for inflamma-
tory mediators in tears of patients with PANDO and if the
culprits are zeroed in on, the search to pharmacologically
block them or their receptors in the lacrimal system may have
prophylactic value early on in the disease. Lacrimal immunol-
ogy work on lacrimal drainage associated lymphoid tissuesProduction and hosting by Elsevier
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from the rest of the immune system should be carried for-
ward to its logical conclusions as this may have great bearing
on our understanding of lacrimal physiology. Other avenues
of potential research in near future include the lacrimal sys-
tem stem cell characterization on similar lines as that of lacri-
mal gland,25 drug coated stents and electron microscopic
inter and intra-cellular changes in lacrimal disorders.
On the second front, the lacrimal surgeon should not only
focus on evidence based practice but also constantly endea-
vor to explore avenues to generate evidence. The research
potential needs to be unlocked and academic institutes
should strive toward protecting and rearing the endangered
species of ‘Clinician-Scientists’ rather than pure clinicians.
The need of the hour is also to cross specialize where it mat-
ters! The lacrimal drainage system has a long course within
the nasal cavity and it is obvious that a good lacrimal work
cannot be done without a good anatomical and surgical
knowledge of the nose. Although, the resurgence of EENT
(eye, ear, nose, and throat) specialists may not be desirable
due to explosion in the knowledge and vast nature of each
subject, the benefits of limited cross specialization cannot
be over emphasized. Cross specialization also opens up the
surgeon to at least some ideas of one’s specialty that when
appropriately extrapolated to other may have beneficial re-
sults. Basic sciences are the key to the future; hence a very
good understanding of fundamentals of lacrimal system up
to the molecular level would greatly help the lacrimal sur-
geon in dealing with the disorders both in the lab and the
clinics. There should be efforts on part of the lacrimal sur-
geon to do focused clinical and research work with an
emphasis on translational values. The challenge of the future
is to set audacious goals and strive hard to achieve them. We
as lacrimal surgeons need to remind ourselves frequently of
our equally important responsibility to advance medicine
and hand it over in a better shape to the next generation
and probably beyond them. Are we doing enough on these
fronts? If not, let us change that from today!
‘‘There is a single light of science, and to brighten it anywhere is
to brighten it everywhere’’. – Isaac Asimov (1920–1992)References
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